ReP USP - Resultado da busca

Filtros : "ANTIVIRAIS" "FMRP-RFA" Removidos: "Akashi, Karen Tiemi" "Tese (Doutorado)" "Even3" Limpar

Filtros

USP affiliated authors
- cunha, fernando de queiroz (2)
- alves filho, josé carlos farias (1)
- batah, sabrina setembre (1)
- cunha, thiago mattar (1)
- damasceno, samara (1)

Indexado em
Collaboration
Normalized affiliation
Non normalized affiliation
- collaborations pharmaceuticals, inc., raleigh (1)
- federal university of rio de janeiro (ufrj), paulo de goes institute of microbiology, department of immunology, rio de janeiro, rj (1)
- federal university of rio de janeiro, faculty of medicine, tuberculosis research laboratory, rio de janeiro, rj (1)
- federal university of santa catarina (ufsc), department of clinical medicine, florianopolis, sc (1)
- federal university of santa catarina (ufsc), department of clinical medicine, florianópolis, sc (1)

Artigo de periodico
Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice (2021)
Puhl, Ana C.; Gomes, Giovanni Freitas; Damasceno, Samara; Fritch, Ethan J.; Levi, James A.; Johnson, Nicole J.; Scholle, Frank; Premkumar, Lakshmanane; Hurst, Brett L.; LeeMontiel, Felipe; Veras, Flávio Protásio; Batah, Sabrina Setembre ; Fabro, Alexandre Todorovic; Moorman, Nathaniel J.; Yount, Boyd L.; Dickmander, Rebekah; Baric, Ralph; Pearce, Kenneth H.; Cunha, Fernando de Queiroz ; Alves Filho, José Carlos Farias; Cunha, Thiago Mattar; Ekins, Sean
Source: bioRxiv. Unidades: FCFRP, FMRP
Subjects: ANTIVIRAIS, ANTINEOPLÁSICOS, CITOCINAS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PUHL, Ana C. et al. Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice. bioRxiv, p. 1-52, 2021Tradução . . Disponível em: https://doi.org/10.1101/2021.12.16.472155. Acesso em: 07 nov. 2024.
APA
Puhl, A. C., Gomes, G. F., Damasceno, S., Fritch, E. J., Levi, J. A., Johnson, N. J., et al. (2021). Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice. bioRxiv, 1-52. doi:10.1101/2021.12.16.472155
NLM
Puhl AC, Gomes GF, Damasceno S, Fritch EJ, Levi JA, Johnson NJ, Scholle F, Premkumar L, Hurst BL, LeeMontiel F, Veras FP, Batah SS, Fabro AT, Moorman NJ, Yount BL, Dickmander R, Baric R, Pearce KH, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice [Internet]. bioRxiv. 2021 ; 1-52.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1101/2021.12.16.472155
Vancouver
Puhl AC, Gomes GF, Damasceno S, Fritch EJ, Levi JA, Johnson NJ, Scholle F, Premkumar L, Hurst BL, LeeMontiel F, Veras FP, Batah SS, Fabro AT, Moorman NJ, Yount BL, Dickmander R, Baric R, Pearce KH, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice [Internet]. bioRxiv. 2021 ; 1-52.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1101/2021.12.16.472155
Artigo de periodico
Neuraminidase inhibitors rewire neutrophil function in vivo in murine sepsis and ex vivo in COVID-19 (2021)
Formiga, Rodrigo Oliveira; Amaral, Flávia Cardoso; Souza, Camila F.; Mendes, Daniel A. G. B.; Wanderley, Carlos Wagner de Souza; Lorenzini, Cristina B.; Santos, Adara A.; Antônia, Juliana; Faria, Lucas F.; Natale, Caio C.; Paula, Nicholas M.; Silva, Priscila C. S.; Fonseca, Fernanda R.; Aires, Luan; Heck, Nicoli; Starick, Márick R.; Barroso, Shana P. C.; Morrot, Alexandre; Weyenbergh, Johan Van; Sordi, Regina de; Alisson-Silva, Frederico; Mansur, Daniel S.; Cunha, Fernando de Queiroz ; Rocha, Edroaldo L.; Witko-Sarsat, Véronique; Burgel, Pierre-Régis; Martin, Clémance; Maurici, Rosemeri; Bafica, Andre; Macauley, Matthew S.; Spiller, Fernando
Source: bioRxiv. Unidade: FMRP
Subjects: GLICOSÍDEOS, SEPSE, NEUTRÓFILOS, COVID-19, ANTIVIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORMIGA, Rodrigo Oliveira et al. Neuraminidase inhibitors rewire neutrophil function in vivo in murine sepsis and ex vivo in COVID-19. bioRxiv, p. 1-68, 2021Tradução . . Disponível em: https://doi.org/10.1101/2020.11.12.379115. Acesso em: 07 nov. 2024.
APA
Formiga, R. O., Amaral, F. C., Souza, C. F., Mendes, D. A. G. B., Wanderley, C. W. de S., Lorenzini, C. B., et al. (2021). Neuraminidase inhibitors rewire neutrophil function in vivo in murine sepsis and ex vivo in COVID-19. bioRxiv, 1-68. doi:10.1101/2020.11.12.379115
NLM
Formiga RO, Amaral FC, Souza CF, Mendes DAGB, Wanderley CW de S, Lorenzini CB, Santos AA, Antônia J, Faria LF, Natale CC, Paula NM, Silva PCS, Fonseca FR, Aires L, Heck N, Starick MR, Barroso SPC, Morrot A, Weyenbergh JV, Sordi R de, Alisson-Silva F, Mansur DS, Cunha F de Q, Rocha EL, Witko-Sarsat V, Burgel P-R, Martin C, Maurici R, Bafica A, Macauley MS, Spiller F. Neuraminidase inhibitors rewire neutrophil function in vivo in murine sepsis and ex vivo in COVID-19 [Internet]. bioRxiv. 2021 ; 1-68.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1101/2020.11.12.379115
Vancouver
Formiga RO, Amaral FC, Souza CF, Mendes DAGB, Wanderley CW de S, Lorenzini CB, Santos AA, Antônia J, Faria LF, Natale CC, Paula NM, Silva PCS, Fonseca FR, Aires L, Heck N, Starick MR, Barroso SPC, Morrot A, Weyenbergh JV, Sordi R de, Alisson-Silva F, Mansur DS, Cunha F de Q, Rocha EL, Witko-Sarsat V, Burgel P-R, Martin C, Maurici R, Bafica A, Macauley MS, Spiller F. Neuraminidase inhibitors rewire neutrophil function in vivo in murine sepsis and ex vivo in COVID-19 [Internet]. bioRxiv. 2021 ; 1-68.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1101/2020.11.12.379115

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024